Furthermore, previous studies have shown that the VEGF-c expression in solid cancers, including endometrial adenocarcinoma, was significantly higher than that observed in adjacent normal tissues [22-24], which is consistent with the data presented in this study. This evidence concerns the gene VEGFC and endometrium adenocarcinoma.